Cofepris facilitates access to innovative medicines

Cofepris, an internal division of the Mexican Ministry of Health, has facilitated the population’s access to safe, effective and high-quality biotechnological and biosimilar medicines.

As most of the medicines consumed in Mexico are manufactured abroad, effective coordination is needed to make them available on the national market. Read more here

If you need more information on drug regulatory issues in Mexico, ELS can certainly help, please do not hesitate to contact your local ELS consultant or via email

Contact us

We will contact you as soon as possible.